This role is an opportunity to pioneer Novo Nordisk’s strategy for small molecule early safety assessment. The position (Senior Scientist II) requires a candidate with deep subject matter expertise in exploratory toxicology for small molecules, and an entrepreneurial spirit to work in the company’s new and growing small molecule pipeline. In this role the candidate will be working together with experienced colleagues in exploratory and computational toxicology and will, as part of the global team, be responsible for small molecule early safety evaluation based on in vitro / in vivo toxicology screening data to support lead optimization and lead candidate selection. An important part of the role is to guide, manage, and interpret toxicity data performed at contract research organizations (CROs) in close collaboration with project scientists and key program stakeholders/leadership. The candidate will be part of a subject matter expert team developing Novo Nordisk’s strategy for early investigative/exploratory toxicology. The expert team will serve a critical advisory function by communicating evaluations and implications of the strategy across the value chain of Novo Nordisk’s small molecule pipeline. The role requires understanding of subject matter & relationship to other key areas related to small molecule drug development; guidance for project team related to experimental strategies to evaluate emerging research and technologies related to small molecules; propose & oversee CROs, external collaborations & strategic partnerships to further develop Novo Nordisk goals related to therapy and/or technology areas, including the use of New Approach Methodologies (NAMs) in toxicology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees